JP2003527844A5 - - Google Patents

Download PDF

Info

Publication number
JP2003527844A5
JP2003527844A5 JP2001558238A JP2001558238A JP2003527844A5 JP 2003527844 A5 JP2003527844 A5 JP 2003527844A5 JP 2001558238 A JP2001558238 A JP 2001558238A JP 2001558238 A JP2001558238 A JP 2001558238A JP 2003527844 A5 JP2003527844 A5 JP 2003527844A5
Authority
JP
Japan
Prior art keywords
polypeptide
pro256
test compound
antibody
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001558238A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003527844A (ja
Filing date
Publication date
Priority claimed from PCT/US2000/003565 external-priority patent/WO2001053486A1/en
Priority claimed from PCT/US2000/006884 external-priority patent/WO2001005972A1/en
Application filed filed Critical
Priority claimed from PCT/US2000/034756 external-priority patent/WO2001059100A2/en
Publication of JP2003527844A publication Critical patent/JP2003527844A/ja
Publication of JP2003527844A5 publication Critical patent/JP2003527844A5/ja
Pending legal-status Critical Current

Links

JP2001558238A 2000-02-11 2000-12-19 血管形成及び心血管疾患の調節に使用する肝細胞成長因子の新規インヒビター Pending JP2003527844A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
PCT/US2000/003565 WO2001053486A1 (en) 1999-03-08 2000-02-11 Compositions and methods for the treatment of tumor
US00/03565 2000-02-11
PCT/US2000/006884 WO2001005972A1 (en) 1999-07-20 2000-03-15 Compositions and methods for the treatment of immune related diseases
US00/06884 2000-03-15
US25366500P 2000-11-28 2000-11-28
US60/253,665 2000-11-28
PCT/US2000/034756 WO2001059100A2 (en) 2000-02-11 2000-12-19 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012160868A Division JP2012246296A (ja) 2000-02-11 2012-07-19 血管形成及び心血管疾患の調節に使用する肝細胞成長因子の新規インヒビター

Publications (2)

Publication Number Publication Date
JP2003527844A JP2003527844A (ja) 2003-09-24
JP2003527844A5 true JP2003527844A5 (enExample) 2011-03-31

Family

ID=39048807

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001558238A Pending JP2003527844A (ja) 2000-02-11 2000-12-19 血管形成及び心血管疾患の調節に使用する肝細胞成長因子の新規インヒビター
JP2012160868A Pending JP2012246296A (ja) 2000-02-11 2012-07-19 血管形成及び心血管疾患の調節に使用する肝細胞成長因子の新規インヒビター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012160868A Pending JP2012246296A (ja) 2000-02-11 2012-07-19 血管形成及び心血管疾患の調節に使用する肝細胞成長因子の新規インヒビター

Country Status (13)

Country Link
US (2) US6800604B2 (enExample)
EP (1) EP1255829B1 (enExample)
JP (2) JP2003527844A (enExample)
AT (1) ATE440139T1 (enExample)
AU (1) AU3075701A (enExample)
CA (1) CA2398775A1 (enExample)
CY (1) CY1109518T1 (enExample)
DE (1) DE60042793D1 (enExample)
DK (1) DK1255829T3 (enExample)
ES (1) ES2330918T3 (enExample)
IL (2) IL150987A0 (enExample)
PT (1) PT1255829E (enExample)
WO (1) WO2001059100A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119113A1 (en) * 1999-07-20 2003-06-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2499896A1 (en) * 2002-10-07 2004-04-22 Genentech, Inc. Hepatocyte growth factor variants
EP1631679A2 (en) * 2003-05-21 2006-03-08 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase 7 (dpp7)
EA015363B1 (ru) 2003-07-18 2011-06-30 Эмджен Инк. Агенты, специфически связывающие фактор роста гепатоцитов, и их применение
BRPI0510206A (pt) * 2004-05-12 2007-10-16 Genentech Inc método de identificação de fenótipo, célula isolada, métodos de identificação de agentes, agentes, agentes terapêuticos, método de avaliação de agente terapêutico, composição farmacêutica, métodos de tratamento, prevenção ou melhoria de disfunções e métodos de modulação
JP2008515992A (ja) 2004-10-13 2008-05-15 ピーティーシー セラピューティクス，インコーポレーテッド 体細胞変異に起因する疾患の阻止／治療用医薬を製造するための規定化合物の使用
US20090136465A1 (en) 2007-09-28 2009-05-28 Intrexon Corporation Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses Thereof
US20110206704A1 (en) * 2009-10-19 2011-08-25 Genentech, Inc. Methods and compositions for modulating hepatocyte growth factor activator
CA2771817A1 (en) * 2009-10-19 2011-04-28 Genentech, Inc. Modulators of hepatocyte growth factor activator
US20130149788A1 (en) * 2011-12-09 2013-06-13 Cornell University Assay for quantifying elemental sulfur levels in a sample
US10743996B2 (en) * 2017-03-24 2020-08-18 Robert L. Bundy Amnion putty for cartilage repair

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
US5382569A (en) 1991-05-16 1995-01-17 Warner-Lambert Company Endotherlin antagonists
CA2158479C (en) 1993-04-05 2009-07-07 Mark T. Keating Diagnosis and treatment of supravalvular aortic stenosis and williams syndrome
US5773223A (en) 1993-09-02 1998-06-30 Chiron Corporation Endothelin B1, (ETB1) receptor polypeptide and its encoding nucleic acid methods, and uses thereof
US5610134A (en) 1994-04-15 1997-03-11 Genentech, Inc. Treatment of congestive heart failure
US5935924A (en) 1994-04-15 1999-08-10 Genentech, Inc. Treatment of congestive heart failure
US5661122A (en) 1994-04-15 1997-08-26 Genentech, Inc. Treatment of congestive heart failure
DK0755446T3 (da) 1994-04-25 2007-01-29 Genentech Inc Cardiotrophin og anvendelser deraf
US5573762A (en) 1995-04-24 1996-11-12 Genentech, Inc. Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy
EP0759467B1 (en) * 1995-07-24 2004-02-11 Mitsubishi Chemical Corporation Hepatocyte growth factor activator inhibitor
WO1997012629A1 (en) * 1995-10-05 1997-04-10 Genentech, Inc. Improved angiogenesis using hepatocyte growth factor
JPH1135480A (ja) * 1997-07-15 1999-02-09 Mitsubishi Chem Corp プロテアーゼの活性亢進に起因する疾患の予防及び／または治療剤
ATE368110T1 (de) 1999-07-20 2007-08-15 Genentech Inc Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten

Similar Documents

Publication Publication Date Title
JP2005046146A5 (enExample)
CA2479476A1 (en) Compositions and methods for the treatment of tumor
JP2010162016A5 (enExample)
CA2414331A1 (en) Pd-l2 molecules: novel pd-1 ligands and uses therefor
JPH05505179A (ja) 新規フィブロネクチンレセプター
CA2265915A1 (en) Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use
JP2011528905A (ja) 抗体レパートリーアレイ（ａｒａ）を使用する標的特異的抗体を発見するための方法および組成物
JP2005027667A5 (enExample)
EP3649145B1 (en) Improved rep protein for use in a diagnostic assay
JP2005518212A5 (enExample)
JP3329811B2 (ja) 合成ＣＤｗ５２（ＣＡＭＰＡＴＨ−１）ペプチド抗原
JP2003531634A5 (enExample)
CA2178057A1 (en) Epstein-barr virus peptides and antibodies against these peptides
JP4041541B2 (ja) エピトープｙｐｙｄｖｐｄｙａに対するモノクローナル抗体、その製造方法および使用方法
JP2006521810A5 (enExample)
JP2006518582A5 (enExample)
CN115667304B (zh) 抗人lag-3抗体及其在免疫组织化学(ihc)中的用途
EP0670908A1 (en) 6-o-methylguanine-dna-methyltransferase (mgmt) specific antibodies
JP2006502738A5 (enExample)
JPH05503849A (ja) Ｔｓｈのヒト受容体及びこの受容体をコードする配列
JP2004515215A5 (enExample)
US6986994B2 (en) INGAP displacement assays
Yoder et al. Identification of a new spore coat protein gene in the cellular slime mold Dictyostelium discoideum
US20090175871A1 (en) Method for demonstrating presence or absence of markers associated with the presence and/or the chemosensitivity of tumors
JP2005528894A5 (enExample)